Hong Kong - Vitalipid N Injections

This is a business opportunity from an overseas buyer. Pitch for the business and explain how your company meets their requirements.

Local authority tender for the supply of Vitalipid N injections.

Details

Opportunity closing date
14 March 2025
Opportunity publication date
28 January 2025
Opportunity type
Public Sector
Industry
Healthcare services, Pharmaceuticals and biotechnology
Enquiries received
0
Value of contract
to be confirmed
Your guide to exporting
Report opportunity

Description

You must be able to supply the following minimum quantities of Vitalipid N (or equivalent) injections:

1.     A minimum quantity of 70,000 ampoules/vials of Vitalipid N Infant (or equivalent) injection, 10ml, preservative free.

Each ml contains:

  • Retinol 69 mcg
  • Ergocalciferol 1mcg
  • Alpha-tocopherol 0.64 mg
  • Phytomenadione 20 mcg

2.     A minimum quantity of 88,200 ampoules/vials of Vitalipid N Adult (or equivalent) injection, 10ml, preservative free.

Each ml contains:

  • Retinol 99 mcg
  • Ergocalciferol 0.5 mcg
  • Alpha-tocopherol 0.91 mg
  • Phytomenadione 15 mcg

Packaging requirements

Requirements are:

  • the immediate container and all levels of packaging of the actual sales pack must include an English translation
  • the expiration date must be expressed in English and/or Arabic numerals in a clear and comprehensible format

Contract

A 3 year contract with a possible extension of up to 24 months.

You must be a UK registered company.

Opportunity closing date

12:00 pm (Hong Kong Time) 14 March 2025

Opportunity closing date
14 March 2025
Value of contract
to be confirmed
The buyer is happy to talk to
manufacturers, wholesalers, distributors, agents

The deadline to apply for this opportunity has passed.
Visit the opportunities page to find another.

Is there anything wrong with this page?